Annual SGA
$14.82 M
-$19.35 M-56.63%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual SGA is $14.82 million, with the most recent change of -$19.35 million (-56.63%) on December 31, 2023.
- During the last 3 years, COEP annual SGA has risen by +$9.05 million (+156.62%).
- COEP annual SGA is now -56.63% below its all-time high of $34.18 million, reached on December 31, 2022.
Performance
COEP SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.08 M
-$1.10 M-50.44%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly SGA is $1.08 million, with the most recent change of -$1.10 million (-50.44%) on September 1, 2024.
- Over the past year, COEP quarterly SGA has dropped by -$2.02 million (-65.19%).
- COEP quarterly SGA is now -93.13% below its all-time high of $15.72 million, reached on March 1, 2022.
Performance
COEP Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$366.33 M
-$12.24 M-3.46%
September 1, 2024
Summary
- As of February 8, 2025, COEP TTM SGA is -$366.33 million, with the most recent change of -$12.24 million (-3.46%) on September 1, 2024.
- Over the past year, COEP TTM SGA has dropped by -$381.15 million (-2571.37%).
- COEP TTM SGA is now -1229.68% below its all-time high of -$27.55 million.
Performance
COEP TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
COEP Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.6% | -65.2% | -2571.4% |
| 3 y3 years | +156.6% | -88.9% | -1138.8% |
| 5 y5 years | +156.6% | -88.9% | -1138.8% |
COEP Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.6% | +5.0% | -93.1% | at low | -1229.7% | at low |
| 5 y | 5-year | -56.6% | +156.6% | -93.1% | at low | -1229.7% | at low |
| alltime | all time | -56.6% | +156.6% | -93.1% | at low | -1229.7% | at low |
Coeptis Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.08 M(-50.4%) | $8.26 M(-15.4%) |
| Jun 2024 | - | $2.18 M(+15.0%) | $9.76 M(-7.5%) |
| Mar 2024 | - | $1.90 M(-38.9%) | $10.54 M(-28.9%) |
| Dec 2023 | $14.82 M(-56.6%) | $3.10 M(+20.3%) | $14.82 M(-0.8%) |
| Sep 2023 | - | $2.58 M(-13.1%) | $14.94 M(-16.3%) |
| Jun 2023 | - | $2.97 M(-51.9%) | $17.85 M(-27.5%) |
| Mar 2023 | - | $6.17 M(+91.8%) | $24.63 M(-27.9%) |
| Dec 2022 | $34.18 M | $3.22 M(-41.4%) | $34.17 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $5.49 M(-43.7%) | $34.00 M(-3.6%) |
| Jun 2022 | - | $9.75 M(-38.0%) | $35.26 M(+25.5%) |
| Mar 2022 | - | $15.72 M(+416.9%) | $28.10 M(+99.0%) |
| Dec 2021 | $14.12 M(+144.5%) | - | - |
| Dec 2021 | - | $3.04 M(-55.0%) | $14.12 M(+27.4%) |
| Sep 2021 | - | $6.76 M(+161.9%) | $11.08 M(+156.4%) |
| Jun 2021 | - | $2.58 M(+48.3%) | $4.32 M(+148.3%) |
| Mar 2021 | - | $1.74 M | $1.74 M |
| Dec 2020 | $5.78 M | - | - |
FAQ
- What is Coeptis Therapeutics annual SGA?
- What is the all time high annual SGA for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual SGA year-on-year change?
- What is Coeptis Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly SGA year-on-year change?
- What is Coeptis Therapeutics TTM SGA?
- What is the all time high TTM SGA for Coeptis Therapeutics?
- What is Coeptis Therapeutics TTM SGA year-on-year change?
What is Coeptis Therapeutics annual SGA?
The current annual SGA of COEP is $14.82 M
What is the all time high annual SGA for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual SGA is $34.18 M
What is Coeptis Therapeutics annual SGA year-on-year change?
Over the past year, COEP annual SGA has changed by -$19.35 M (-56.63%)
What is Coeptis Therapeutics quarterly SGA?
The current quarterly SGA of COEP is $1.08 M
What is the all time high quarterly SGA for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly SGA is $15.72 M
What is Coeptis Therapeutics quarterly SGA year-on-year change?
Over the past year, COEP quarterly SGA has changed by -$2.02 M (-65.19%)
What is Coeptis Therapeutics TTM SGA?
The current TTM SGA of COEP is -$366.33 M
What is the all time high TTM SGA for Coeptis Therapeutics?
Coeptis Therapeutics all-time high TTM SGA is -$27.55 M
What is Coeptis Therapeutics TTM SGA year-on-year change?
Over the past year, COEP TTM SGA has changed by -$381.15 M (-2571.37%)